Urology Doctors in Wauwatosa, WI Accepting Medicare

4 Urology doctors found. Showing 1 - 4

William H Annesley Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1547 Upper Pkwy S, Wauwatosa, WI 53213 Phone: 414-254-5610    Fax: 414-755-7576

John Patrick Walsh, MD Urology Medicare: Medicare Enrolled Practice Location: 2600 N Mayfair Rd, Suite 545, Wauwatosa, WI 53226 Phone: 414-476-0430    Fax: 414-476-3242

Kohldon Carter Boydston, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2600 N Mayfair Rd Ste 545, Wauwatosa, WI 53226 Phone: 414-476-0430

Christopher John Walsh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2600 N Mayfair Rd, Ste 545, Wauwatosa, WI 53226 Phone: 414-476-0430    Fax: 414-476-3242

News Archive

Pacific Beach BioSciences signs licensing agreement with major pharmaceutical company

Pacific Beach BioSciences, Inc. today reported that it has granted non-exclusive rights to a large pharmaceutical company for the use of one of its anti-fungal compounds required for the manufacturing of a clinical stage product.

mRNA COVID-19 vaccines induce high antibody titers with significant neutralizing potency in saliva

Scientists from the USA and Canada have recently demonstrated that the dynamics of antibody response induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (COVID-19) vaccines are different.

New motivations to serve vegetables to kids

Parents may have some new motivations to serve their kids vegetables. A new study, funded by Pinnacle Foods' Birds Eye brand and published in Public Health Nutrition, found that adding vegetables to the plate led to more positive evaluations of both the main entr-e and the cook. By simply serving vegetables with dinner, participants believed the main course would taste better and thought the server was more thoughtful and attentive.

Seattle Genetics, Agensys present ASG-5ME ADC preclinical data at 101st AACR

Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today reported preclinical data with ASG-5ME, an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors. In models of human prostate and pancreatic cancer, ASG-5ME was found to have potent and long lasting antitumor activity. The findings were presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.

Vanguard Health Systems extends consent payment deadline

Vanguard Health Systems, Inc. ("Vanguard") announced today that in connection with the previously announced tender offers and consent solicitations (the "Tender Offers" and "Consent Solicitations") by Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Health Holding Company I, LLC ("VHS Holdco I"), the early tender period in respect of each of the Tender Offers will be extended to 5:00 p.m., New York City time, on January 29, 2010 (the "New Consent Payment Deadline").

Read more Medical News

› Verified 5 days ago